Atrial fibrillation, or A-fib, is becoming more common, but doctors say treatments are improving. The condition is a quivering or irregular heartbeat.

Volt Pulsed Field Ablation System (PFA) is being trialed for the first time in the UK at Belfast Royal Victoria Hospital (RVH ...

In patients with COPD and atrial fibrillation or flutter, vitamin K antagonists carry a lower 1‑year risk for hospitalization ...

Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium.

Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation ...

AOP Health US, LLC has been awarded a Pharmaceutical national group purchasing agreement with Premier, Inc. Effective August ...

dvances in technology have contributed to medical care in many ways, including helping patients catch heart issues early, ...

Johnson & Johnson (NYSE:JNJ) reports strong 12 month pilot-phase data for its OMNYPULSE platform in atrial fibrillation ...

February is Heart Month and Dr. James Storey, a cardiac electrophysiologist, discusses top concerns regarding heart health with KC Counts.

The need for aFIB awareness is growing, with a recent study by the CDC projecting a huge spike in cases by 2030—over 12 ...

TCTMD spoke with Lior Jankelson, MD, PhD (NYU Langone Health, New York, NY), an electrophysiologist who leads the AI/machine ...

Background Patients with heart failure (HF) and severe mitral regurgitation (MR) have poor outcomes. Early identification ...